Agatolimod [PF-3512676] has potential as an adjuvant therapy in malignant melanoma

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers

By Tarhini Ahmad A   Kirkwood John M   Krieg Arthur M  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 5, 2009-05 ,pp. : 587-603

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

By Manuja Anju   Manuja Balvinder K.   Kaushik Jyoti   Singha Harisankar   Singh Raj Kumar  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 5, 2013-10 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite

PF1022A and Related Cyclodepsipeptides - A Novel Class of Anthelmintics

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 7, 2002-06 ,pp. : 759-777

Bentham Science Publishers

Access to resources Recommend Favorite

Immune effects and therapeutic applications of CpG motifs in bacterial DNA

By Krieg A.M.   Kline J.N.  

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 303-305

Elsevier

Access to resources Recommend Favorite